Polycystic ovary syndrome is a common endocrinopathy characterized by oligo ovulation or anovulation, signs of androgen excess and multiple small ovarian cysts. It includes various metabolic abnormalities: insulin resistance, hyperinsulinemia, impaired glucose tolerance, visceral obesity, inflammation and endothelial dysfunction, hypertension and dyslipidemia. All these metabolic abnormalities have long-term implications. Treatment should be individualized and must not address a single sign or symptom. Studies are still needed to determine the benefits and the associated risks of the medication now available to practitioners.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
polycystic ovary
8
ovary syndrome
8
metabolic abnormalities
8
treatment metabolic
4
metabolic alterations
4
alterations polycystic
4
syndrome polycystic
4
syndrome common
4
common endocrinopathy
4
endocrinopathy characterized
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!